Introduction
Myelination of axons is tightly regulated during postnatal mammalian development to achieve efficient neurotransmission in concert with the maturation of neuronal circuits (Simons and Lyons, 2013; Bercury and Macklin, 2015) . This pattern of myelination is modulated by the generation of oligodendrocyte progenitor (OP) cells, which then differentiate into myelinating oligodendrocytes. Signaling molecules that regulate progressive stages from OP generation through myelination are critical to understand in order to develop strategies to mitigate developmental disabilities associated with myelination. These cellular processes and signaling molecules can also provide insights into the design of therapeutics to improve the capacity of OP cells to repair myelin in the adult CNS after an episode of demyelination (Franklin and Gallo, 2014; Chamberlain et al., 2016) .
Indeed, the developmental origin of OP cells has recently been shown to influence their regenerative properties during remyelination in adulthood (Crawford et al., 2016) . The corpus callosum (CC) is populated by OP cells derived from both ventral (Gsh2) and dorsal (Emx1) regions of the ventricular zone during late embryonic and early postnatal development, respectively (Kessaris et al., 2006; Tripathi et al., 2011) . The dorsal (Emx1) derived cells account for the majority of the oligodendrocytes in the postnatal and adult CC (Tripathi et al., 2011; Crawford et al., 2016) . After an episode of demyelination, OP cells derived from the dorsal (Emx1) domain repopulated the CC and dominated the remyelination response (Crawford et al., 2016) .
We initiated studies to decipher the signaling molecules that are active during the postnatal amplification of the dorsally derived OP cells which later in life contribute to the remyelination response in the CC. We hypothesized that Sonic hedgehog (Shh) signaling may be an important candidate pathway. In the postnatal and adult ventricularsubventricular zone (V-SVZ), Shh regulates proliferation of activated neural stem cells and is required to maintain progenitor populations in the telencephalon (Machold et al., 2003; Palma et al., 2005; Daynac et al., 2016) . Relative to oligodendrogenesis, Shh signaling regulates the postnatal wave of oligodendrocyte production from the dorsal V-SVZ to populate the CC prior to myelination (Tong et al., 2015) . This postnatal Shh signaling for OP cell generation activates Gli1 transcription, which is an effective readout of the canonical Shh pathway (Ahn and Joyner, 2004; Tong et al., 2015) . However, given the complex and dynamic regulatory interactions of the developing V-SVZ, it is important to determine whether the postnatal Shh responsive cells are part of the dorsally derived population that generates progenitors which contribute to remyelination. Therefore, the current studies focus on the postnatal period of OP amplification and oligodendrogenesis to determine whether Shh responsive cells generate oligodendrocyte lineage cells that contribute to remyelination.
Our studies used induced genetic fate labeling for in vivo cell tracking based on postnatal Shh signaling. Gli1
CreERT2 mice were crossed to R26 tdTomato or R26 IAP reporter lines to evaluate the distribution of Shh responsive cells in the CC. This heritable approach enabled the Shh responsive population to have expression of the reporter gene, either tdTomato or alkaline phosphatase, induced by tamoxifen (TMX) administration during early postnatal development. The fate and distribution of these genetically labeled cells was then analyzed in the CC after short intervals to examine postnatal myelination, and at much longer intervals to examine the contribution to adult CC populations.
Complementary analysis of Shh responsive cells using the Gli1
CreERT2 line and Shh synthesizing cells using the Shh CreERT2 line examined the postnatal period of active Shh signaling during the progression of myelination in the CC. Healthy adult Gli1 CreERT2 mice were analyzed to identify the CC cell types that were generated from the postnatal Gli1 fate-labeled population under homeostatic conditions. Cuprizone (CPZ) mediated demyelination in adult Gli1 CreERT2 mice was used to test whether the postnatal Gli1 fate-labeled population continued to generate oligodendrocyte lineage cells that contributed to remyelination of the CC. Together, these experiments identify a transient postnatal Shh responsive cohort that gives rise to cells which contribute to CC myelination during development and in adulthood continue to generate oligodendrocyte lineage cells for homeostasis and for myelin repair.
Methods

Mice for genetic inducible fate labeling
Mice were housed and cared for in accordance with the guidelines of the National Institutes of Health and the Institutional Animal Care and Use Committee of the Uniformed Services University of the Health Sciences. Shh
CreERT2
(B6.129S6-Shh tm2(cre/ERT2)Cjt /J; Jackson Laboratories, 005623, Bar Harbor, ME) or Gli1
CreERT2 (Gli1 tm3(cre/ ESR1)Alj /J; Jackson Laboratories, 007913, Bar Harbor, ME; provided by Dr. Sohyun Ahn, National Institutes of Health) mice express Cre recombinase fused to a mutated estrogen receptor, which requires TMX binding for nuclear translocation (Ahn and Joyner, 2004; Harfe et al., 2004; Ahn and Joyner, 2005 (Badea et al., 2009) . TMX (4-hydroxytamoxifen, H7904, Sigma, St. Louis, MO) was dissolved in sunflower seed oil (S5007, Sigma) to a concentration of 4 mg/ml and delivered via intraperitoneal injection (0.033 mg/g) on each of four consecutive days, either postnatal day 6-9 (P6-9) or P14-17. Analysis included both male and female mice, as noted in the figure legends. Male mice were used for demyelination since CPZ results in similar demyelination in male and female mice but causes toxicity resulting in estrus cycle disruption in female C57BL/6 mice, so that gender differences cannot be appropriately examined (Taylor et al., 2010) . Female mice were used for the analysis of the normal conditions during postnatal myelination through to adulthood.
Demyelination of the corpus callosum
Acute demyelination in the CC was induced in 8 week old Gli1
CreERT2
; R26
IAP male mice by adding 0.3% CPZ to the chow pellets for 6 weeks. After acute demyelination, mice used for analysis of remyelination were given normal chow during a 3 week recovery period after removal of CPZ from the diet. Chronic demyelination was induced in Gli1 CreERT2 ; R26 tdTomato and
Gli1
CreERT2
; R26 IAP mice by adding 0.3% CPZ to the chow pellets for 12 weeks. Gli1
; R26 tdTomato mice were perfused 6 days after removal of CPZ from the diet. Gli1
; R26 IAP were perfused either at the end of the 12 week CPZ exposure or after a subsequent 6 weeks on normal chow for analysis of remyelination.
Immunohistochemistry and reporter detection
Mice were perfused with 3% paraformaldehyde at time points noted in the results for analysis of postnatal development, or as adults with or without CPZ treatment. Brains were further post-fixed by immersion overnight in 3% paraformaldehyde. Female mice were used for analysis of Gli1 or Shh fate labeling at P11, P13, P14, P28 and P56. Male mice were used for CPZ studies including age matched control mice perfused at P119, P146 and P182. Coronal sections (14 μm) were used for immunohistochemistry or reporter detection, except for Shh CreERT2 ; R26 IAP tissue which was better visualized in 20 μm sections. Antibody information is provided in Table 1 . Myelin was immunostained for myelin oligodendrocyte glycoprotein (MOG) (Linington and Lassmann, 1987; Breithaupt et al., 2003) . Oligodendrocyte lineage cells were identified by Olig2 expression. OP cells were identified as being small, elongated process-bearing cells immunolabeled for NG2. CC1 was used as a marker for mature oligodendrocyte. GFAP was used as a marker for astrocytes in the corpus callosum and neural stem cells in the V-SVZ. Neurons were identified detection of NeuN. TdTomato reporter signal was visible without additional processing. AP activity was detected as previously described (Mierzwa et al., 2014) . Briefly, endogenous AP activity was deactivated by incubating mounted brain section in heated phosphate buffer saline (69°C for 90 min). Sections were then incubated in nitro-blue tetrazolium chloride (NBT)/5-bromo-4-chloro-3-indoly-phosphate toluidine salt (BCIP) substrate (DAKO, Cat. #: K0598) overnight followed by nuclear staining with methyl green (Vector Laboratories, Cat #: SP5000).
Cell proliferation in vivo
Ki67 antigen detection (Table 1 ) was used to identify cells in an active stage of cell division at the time of perfusion. An ABC kit (Vector Laboratories) was used to detect biotinylated Ki67 antibody followed by brown diaminobenzidine enzymatic reaction (Vector Laboratories) in Gli1
CreERT2
;R26 IAP mice and combined with the NBT/BCIP reaction to detect AP (see above). To label cycling cells based on DNA synthesis, Gli1
;R26 tdTomato mice were injected i.p. with 5-ethynyl-2′-deoxyuridine (EdU) (100 mg/kg). Healthy adult mice were given two injections of EdU at 12 h apart and perfused 12 h after the second EdU injection on P56. Chronically demyelinated and age-matched control Gli1
; R26 tdTomato mice received EdU over five days at 12 h intervals (10 injections in total) starting 2 h after the end of CPZ treatment. Mice were perfused 12 h after the last EdU injection. EdU was detected in tissue sections using a Click-iT ® Plus EdU kit (C10637; Life Technologies).
Image acquisition, quantification and statistical analysis
Fluorescent images were acquired using a SPOT RT3 camera (Diagnostic Instruments, Sterling Heights, MI) or a Zeiss LSM 700 (Carl Zeiss Microscopy, Thornwood, NY). AP and Ki67 reactions were digitized using a NanoZoomer 2.0-RS (Hamamatsu Instruments, Hamamatsu, Japan). Quantification of each region-of-interest (Fig. S1 ) included 3 sections per animals with at least 3 animals per group, unless otherwise specified. The CC was subdivided into medial and lateral regions in coronal sections to enable quantification based on the developmental progression of myelination in postnatal mice (Vincze et al., 2008) . The medial CC region was defined as the region from the midline to point under the peak of the cingulum. The lateral CC region extended from the point under the peak of the cingulum laterally to edge of the lateral ventricle. Rostral through caudal regions of the CC were examined qualitatively. Quantitative analysis focused on the caudal region of the CC over the hippocampus between approximately −1.06 to − 2.30 mm from bregma (Franklin and Paxinos, 1997) , where CPZ demyelination is prominent (Xie et al., 2010) . Spot Advanced Software (http://www.spotimaging.com; RRID: SCR_014313; Spot imaging solutions, Sterling Heights, MI) was used to measure the area of each region-of-interest. The areas of MOG immunolabeling and AP reaction in the CC were estimated based on the number of pixels with intensities above the background intensity level using the thresholding function in MetaMorph software (https://www.moleculardevices.com; RRID: SCR_002368; Molecular Devices, Downingtown, PA Both quantitative and qualitative analyses were performed with blinding and the number of mice included in each analysis is listed in each figure legend. Myelination progression was analyzed using oneway analysis of variance followed by Dunnett's post hoc comparison to P56. Two-way analysis of variance was used to analyze cells in the CC as well as AP labeling in the CC. Sidak's multiple comparisons test was used for posthoc analysis. Statistical significance was set as p < 0.05.
Results
Shh responsive cells populate mainly lateral CC regions during early postnatal myelination
Gli1
CreERT2 ; R26 tdTomato mice were used for induced genetic fate labeling of cells responding to canonical Shh signaling during postnatal myelination of the CC (Fig. 1 ). Mice were given TMX on postnatal days 6-9 (P6-9) to examine Shh signaling during the period when oligodendrocytes populate the CC (Vincze et al., 2008) . When mice were perfused on P10, Gli1 fate-labeled cells expressing tdTomato reporter (Gli1-Tom) were prominent in the V-SVZ (Fig. 1A-D) . In addition, Gli1-Tom cells were detected in the lateral CC in coronal sections from both rostral and caudal levels of the brain (Fig. 1A-D) . Extending the time after TMX until P14 resulted in higher levels of reporter expression, which facilitated double labeling with Olig2 to identify oligodendrocyte lineage cells among the Gli1-Tom cells in the CC (Fig. 1E) .
To examine the distribution of Gli1 fate-labeled cells relative to the progression of CC myelination, Gli1
CreERT2 ; R26 tdTomato mice were given TMX from P6-9 and analyzed at P14, P21, P28 and P56 ( Fig. 2A ). Across these time points, immunolabeling of myelin for MOG demonstrated a lateral to medial progression of myelination in the CC that was evident at the early time points, i.e. P14 ( Fig (Vincze et al., 2008) . The vast majority of Gli1-Tom cells were localized in the lateral CC, as compared to the medial CC (Fig. 2L ). These Gli1-Tom cells could be the initial cells that underwent recombination, or the progeny that inherited the recombined transgene for reporter expression. The density of Gli1-Tom cells did not redistribute in step with the progression of myelination in the medial CC. Gli1-Tom cells were maintained in the lateral CC at similar levels out to adulthood, i.e. P56. Gli1-Tom cells were also distributed within the cerebral cortex (Fig. 2C, F, I ). Prior studies from our lab and others have identified similar Gli1 fate-labeled cells as a subpopulation of cortical astrocytes in adult mice (Garcia et al., 2010; Mierzwa et al., 2014) .
Transient postnatal Shh responsive population elaborates myelin-like membranes in postnatal and adult CC
Gli1
CreERT2 mice were crossed to R26 IAP mice to visualize membranes formed by Gli1 fate-labeled (Gli1-AP) cells during postnatal myelination (Fig. 3) . When TMX was administered at P6-9, Gli1-AP cells accumulated in the lateral CC at P21, P28, and into adulthood (P56) (Fig. 3A-D) . Moreover, the AP reaction revealed that Gli1-AP cells elaborated membranes that extended from P21 ( Fig. 3B , E) to P28 (Fig. 3C , F) in the plane of CC axons and appeared in clusters consistent with a myelin morphology in P56 adult mice (Fig. 3D, G) . The distribution of Gli1-IAP cells was also examined at rostral levels in adults and again Gli1-IAP cells were mainly found in the lateral CC regions adjacent to the V-SVZ (Fig. S2 ).
In contrast to these findings with TMX on P6-9, studies using the Gli1
CreERT2 line with TMX administered in adult mice have shown only rare labeling of cells in the CC (Garcia et al., 2010; Mierzwa et al., 2014) . It is not clear at what point during postnatal development Gli1 expression is down-regulated among cells that go on to populate the CC. Therefore, we next delayed TMX administration until after the peak of oligodendrogenesis for analysis at a later stage in the progression of CC myelination (Sauvageot and Stiles, 2002) . The delay of TMX to P14-17 significantly reduced the density of Gli1 fatelabeled cells in the CC (Fig. 3H-L ). Differential Shh signaling may occur among cortical regions in comparison with the CC. Analysis of the cerebral cortex in caudal regions showed a lateral distribution of Gli1-AP cells in mice given TMX from P6-9 in caudal regions (Fig. S2 ). However, in rostral regions, cortical Gli1-AP cells were localized in medial regions (Fig. S2 ). Cortical Gli1-AP cells were also present at much lower levels with TMX administered from P14-17, in comparison with P6-9 (Fig. S2 ).
Primary cilia required for Shh signaling are present in the CC of adult mice
Activation of canonical Shh signaling and subsequent expression of Gli1 is dependent on the translocation of Smoothened (Smo) to the primary cilium (Nozawa et al., 2013) . Previous studies have shown that primary cilia are found on immature oligodendrocyte lineage cells and lost during differentiation into myelinating cells (Falcon-Urrutia et al., 2015; Subedi and Fuchs, 2016) . To investigate if loss of primary cilia could explain the reduction in Gli1 expression after the second postnatal week, tissue sections were immunolabeled to detect Arl13b, which is a marker of cilia and regulates Smo entry into the cilium (Larkins et al., 2011) (Fig. S3 ). Cilia were examined in either C57BL/6J mice at P7 or in Gli1
CreERT2
; R26 tdTomato mice given TMX at P6-9 that were perfused at P14, P21 and P56. Arl13b labeled small rod shaped structures in cells of the choroid plexus and ependyma, which served as internal positive controls for immunolabeling of cilia that are known to regulate the circulation of cerebral spinal fluid (Tong et al., 2014) . Arl13b labeling consistent with the morphology of primary cilia was also found in the V-SVZ, the CC, and the cortex. Compared to P7, lower densities of Arl13b labeling continued to be detected in the cortex and in the CC at P14, P21, and P56. Therefore, loss of primary cilia is not likely to fully account for the lack of Gli1 fate-labeling in the CC with TMX administered at P14-17. CreERT2 ; R26 tdTomato mice were administered TMX from postnatal day 6-9 (P6-9) to induce genetic fate-labeling of cells expressing Gli1, which is an effective readout of Shh signaling (A). In mice perfused on P10, the tdTomato (Tom) reporter expression in Gli1 fate-labeled (Gli1-Tom) cells was strong in the dorsal and ventral regions of the V-SVZ, respectively labeled dV-SVZ and vV-SVZ, along the lateral wall of the lateral ventricle (LV) (B). The yellow line divides the CC under the peak of the cingulum (Cg) designating regions as medial (M_CC) and lateral (L_CC) (B). Higher magnification shows small process-bearing Gli1-Tom cells in the white matter tracts of the CC and Cg (C). Gli1-Tom cells are also found along the lateral wall of the lateral ventricle, in the subcallosal zone (SCZ), and distributed within the L_CC in sections from more caudal brain regions (D). In mice with perfusion delayed until P14, immunohistochemistry for Olig2 identifies oligodendrocyte lineage cells among the Gli1-Tom cells in the CC (E; arrows show example of Gli1-Tom cell with nuclear Olig2; enlarged as inset). Images shown are representative from n = 4 (P10) and n = 4 (P14) female mice. Scale bar in B = 400 μm, C, D = 200 μm, E = 100 μm.
Transient Shh ligand fate-labeling of neuronal populations during postnatal myelination
Shh CreERT2 mice were used to investigate Shh ligand synthesis relative to the temporal and spatial patterns of Gli1 fate-labeling observed with TMX administered from P6-9 ( Fig. 4A-F 
; R26 tdTomato mice given TMX on P6-9 showed that neurons in the cortex and in multiple ventral regions are the major source of Shh ligand, i.e. tdTomato labeled based on transcription from the Shh promoter ( Fig. 4C-E) . Shh-Tom cortical neurons were localized mainly in the somatosensory and motor regions at rostral levels ( Fig. 4B ) as well as in the retrosplenial region at caudal levels (Fig. 4C) . Shh-Tom neurons were markedly reduced in the cerebral cortex when TMX was delayed until after the second postnatal week (Fig. 4G-I ). ShhTom cells in regions adjacent to the V-SVZ were also identified by cell type-specific markers (Fig. 5 for P6-9 TMX; unpublished data for P14-17 TMX). Shh-Tom cells were only rarely exhibited an astrocytic morphology or GFAP immunoreactivity while the majority of Shh-Tom cells had a neuronal morphology which was confirmed with NeuN immunolabeling (Fig. 5) . Shh CreERT2 ; R26 IAP mice were used so that the AP reaction and a longer survival time after TMX administration could increase the detection of the neuronal morphology and distribution of Shh transcribing cells across brain regions (Fig. 4) . Mice fate labeled at P6-9 and perfused at P21 showed Shh-AP labeling in neurons in somatosensory, motor, and retrosplenial regions of cortex ( Fig. 4D-F) , consistent with our findings with tdTomato reporter. At rostral levels, Shh-AP labeling also indicates Shh synthesis in cells of multiple ventral regions and particularly high expression in the claustrum (Fig. 4E) . Delaying TMX to P14-17 reduced Shh-AP labeling in the cortical neurons, including somatosensory neurons at both rostral and caudal levels ( Fig. 4J-L) . Shh-AP labeling in the claustrum was strong with TMX at both P6-9 and P14-17 and served to confirm adequate AP reaction across tissue sections (Fig. 4E, K) . R26 tdTomato mice were administered TMX from postnatal day 6-9 (P6-9) to induce genetic fate-labeling of cells expressing Gli1 (A). The CC was analyzed for myelination and tdTomato (Tom) reporter expression in Gli1 fate-labeled (Gli1-Tom) cells at P14 (B-D), P21 (E-G), P28 (not shown) and P56 (H-J). The yellow line across the CC under the peak of the cingulum (cg) divides the CC regions into medial (M_CC) and lateral (L_CC) (B-J). Immunohistochemistry (IHC) to detect myelin oligodendrocyte glycoprotein (MOG) demonstrates the lateral to medial progression of myelination in the CC between P14-P56 (B, E, H). Myelination in the M_CC is delayed compared to myelination in the L_CC (K). Gli1-Tom cells are localized mainly in the lateral CC during postnatal myelination (C, F) and this pattern is maintained in adult mice (I). The low density of Gli1-Tom cells in the medial CC (L) does not increase in parallel with postnatal myelination (K). One-way ANOVA, Dunnett's multiple comparisons to P56 (K). Two-way ANOVA (L). Female mice used in quantification: n = 4 for P14, P21 and P56; n = 3 for P28. Scale bar = 400 μm.
Postnatal Shh responsive cells proliferate in germinal niches and CC into adulthood
We next asked whether the transient postnatal Shh responsive cell population may contribute to the adult regenerative potential, i.e. capacity to generate new cells. Immunohistochemistry for Ki67 was used to identify cycling cells in sections from Gli1
CreERT2
; R26 IAP mice given TMX on P6-9 (Fig. 6 ). Gli1-AP cells exhibited Ki67 nuclear immunoreactivity in each of the major germinal zones of the adult brain -the V-SVZ (Fig. 6B ), subgranular zone (Fig. 6C) , and subcallosal zone (Fig. 6D) . In the CC, cycling cells were abundant at P28 (Fig. 6E) , as expected during late postnatal myelination, whereas fewer cycling cells were observed in adult P56 mice (Fig. 6F) . Interestingly, Gli1-AP cells were double labeled for Ki67 in the CC at P28 (Fig. 6E inset) and at P56 (Fig. 6F inset) .
Postnatal Shh responsive cells generate cycling oligodendrocyte lineage cells in adult CC
The regenerative potential of the Gli1-Tom fate labeled population in adult mice was further examined based on incorporation of EdU during DNA synthesis and immunolabeling to identify actively proliferating Shh responsive cells that can give rise to oligodendrocyte lineage cells (Figs. 7, 8 ). Gli1
CreERT2 ; R26 tdTomato mice given TMX at P6-P9 were administered EdU on P56 (Figs. 7A, 8A) . We examined the V-SVZ to determine whether postnatal Gli1 fate-labeled parent cells or their progeny continued to be present in the adults (Fig. 7) . Gli1-Tom cells persisted in dorsal and ventral regions of the V-SVZ cells, and included cycling cells that incorporated EdU (Fig. 7B ). These observations indicate that TMX on P6-9 heritably labels self-renewing neural stem cells that continue to give rise to transient amplifying cells in adults. Consistent with this interpretation, immunolabeling for GFAP demonstrated Gli1-Tom labeling of neural stem cells in the V-SVZ at P56 (Fig. 7C-E ). In addition, NG2 was expressed by Gli1-Tom cells in the region that extends from the V-SVZ under the CC (Fig. 7B) . More specific analysis of the oligodendrocyte lineage focused on the CC in adult Gli1
CreERT2 ; R26 tdTomato mice to examine the fate of the Gli1-Tom population that was heritably labeled with TMX from P6-9 (Fig. 8 ). Olig2 nuclear immunoreactivity identifies oligodendrocyte lineage cells from OP cells through mature oligodendrocytes. Olig2 immunolabeling demonstrated that Gli1-Tom cells in the CC included oligodendrocyte lineage cells (Fig. 8B) . Many of the Gli1-Tom cells with nuclear Olig2 were aligned in rows that are characteristic of interfascicular oligodendrocytes (Fig. 8B) . OP cells can continue to proliferate in the CC and give rise to myelinating oligodendrocytes into adulthood (Dawson et al., 2003; Murtie et al., 2005; Armstrong et al., 2006) . Indeed, Gli1-Tom cells in the CC included NG2 immunolabeled cells with small cell bodies and processes characteristic of OP cells (Fig. 8C, D) . EdU incorporation enabled detection of cells in the CC that had undergone mitosis during the day prior to perfusion ( Fig. 8D ). Gli1-Tom cells were identified as cycling OP cells by triple labeling for tdTomato, NG2, and EdU and often appeared as doublets, consistent were given tamoxifen (TMX) from postnatal days 6-9 (P6-9) (A-G) or from P14-17 (H-K).
Representative images show alkaline phosphatase (AP) reaction in Gli1 fate-labeled (Gli1-AP) cells distributed mainly in the lateral corpus callosum (L_CC) with few in the medial region (M_CC) when analyzed at P21 (B), P28 (C), or P56 (D). Gli1-AP cells initially have short processes at P21 (E) that become more extensive and aligned along the plane of CC axons by P28 (F), and exhibit a myelin-like morphology by P56 (G). When TMX administration was delayed until P14-17 (H), Gli1-AP labeling was dramatically reduced across all time points examined (I-K). Quantification shows the more lateral distribution of Gli1-AP cells in the CC of mice given TMX at P6-9 and the significant loss of Gli1-AP labeling with TMX given at P14-17 (L). Female mice used in quantification: n = 4 with TMX at P6-9 for P21, P28 and P56); n = 3 with TMX at P14-17 for P21 and P56; n = 5 with TMX at P14-17 for P28. Scale bar in K = 400 μm for B-D and I-K; in E-G = 50 μm.
with recent cell division (Fig. 9D, inset) . Gli1-Tom fate-labeling from P6-9 was not specific to the oligodendrocyte lineage as Gli1-Tom astrocyte populations were also present in the adult CC and cortex (Fig. 9) .
Postnatal Shh responsive cells continue to generate oligodendrocyte lineage cells after acute and chronic demyelination with CPZ
The regenerative potential of postnatal Shh responsive cells was investigated during the course of CC demyelination and remyelination using the CPZ model. We first examined an acute demyelination protocol which undergoes effective remyelination after the removal of CPZ from the diet (Davidson et al., 2017) . Gli1
CreERT2
; R26 IAP mice given TMX on P6-9 were fed CPZ starting from P56 (8 weeks of age) and continuing for 6 weeks, with or without a subsequent 3 week period on normal chow to allow for remyelination (Fig. 10A ). Gli1
; R26 IAP mice given TMX on P6-9 and perfused at P56 were used as controls without demyelination (No CPZ). Control mice illustrate normal myelination of the CC with MOG immunolabeling of myelin (Fig. 10B ).
Gli1-AP cells extend clusters of thin membranes parallel to axons consistent with myelin formation in the CC (Fig. 10C-D) . After 6 weeks of CPZ, CC demyelination is evident from loss of MOG immunoreactivity (Fig. 10E ). Gli1-AP cells in the CC have thickened processes (Fig. 10F-G) . After a 3 week period for recovery, MOG immunolabeling is again detected across the CC (Fig. 10H) . Consistent with remyelination, Gli1-AP cells in the CC exhibit long, thin membranes with myelinlike morphology (Fig. 10I-J) . These findings indicate that postnatal Shh responsive cells contribute to remyelination after acute demyelination. We next tested the potential of postnatal Shh responsive cells to contribute to remyelination after chronic demyelination in the CPZ model (Figs. 11, 12 ). Chronic CPZ administration results in continued death of oligodendrocytes, and the OP population that is amplified during acute CPZ demyelination is reduced during chronic CPZ demyelination (Armstrong et al., 2006) . Therefore, the regenerative potential of the postnatal Gli1 fate-labeled cells is important to examine in this chronic lesion context. Gli1
; R26 tdTomato mice given TMX on P6-9 were fed CPZ for 12 weeks to induced chronic demyelination in the CC. At the end of CPZ, Gli1 CreERT2 ; R26 tdTomato mice were returned to analyzed at P21 or P28. Scale bars in B = 100 μm for B-C and H-I; in E, F, K, L = 500 μm.
normal chow and administered EdU every 12 h for 5 days. Mice were perfused 12 h after the last dose of EdU (Fig. 11A ). Gli1-Tom cells in the CC continued to localize to lateral CC more frequently than to medial CC in both chronically demyelinated mice and age matched control mice (No CPZ) (Fig. 11B) . Therefore, Gli1-Tom cells did not redistribute into the medial CC after CPZ demyelination. However, chronic demyelination significantly reduced the density of Gli1-Tom cells in the lateral CC, as compared to control mice (Fig. 11B) . Chronic demyelination also caused an obvious change in the morphology of Gli1-Tom cells in the CC. This change in Gli1-Tom cell morphology is consistent with the morphology previously characterized for reactive astrocytes in the CC after chronic CPZ (Hibbits et al., 2012) . Immunohistochemistry with GFAP identified Gli1-Tom cells with normal white matter astrocyte morphology in the CC of control mice (Fig. 11C ) and reactive astrocytes in the chronic CPZ mice (Fig. 11D) . To examine the contribution of Gli1-Tom cells to oligodendrocytes relative to remyelination, immunolabeling with CC1 was used to identify oligodendrocytes and EdU incorporation distinguished oligodendrocytes generated after chronic demyelination ( Fig. 11E-P) . In control mice, Gli1-Tom cells in the CC were often immunolabeled for CC1 but did not incorporate EdU (Fig. 11E-H) . After chronic demyelination, Gli1-Tom cells contributed to newly generated oligodendrocytes based on labeling for CC1 and EdU incorporation ( Fig. 11I-P) . Gli1-Tom cells with the morphology of reactive astrocytes also proliferated after chronic demyelination ( Fig. 11M-P) . The generation of new oligodendrocytes from Gli1-Tom cells during the first 6 days after ending chronic CPZ was further examined by quantitative analysis of cell proliferation and OP cells that give rise to oligodendrocytes during remyelination (Fig. 12A ). After chronic demyelination, cell proliferation in the CC was significantly increased overall and within the Gli1-Tom population (Fig. 12B-E) . Small, elongated process bearing OP cells immunolabeled for NG2 were also increased in the CC after chronic demyelination (Fig. 12F-H) . Posthoc analysis showed the total OP cell increase to be significant due to the increase in the medial CC (Fig. 12H) . In contrast, the Gli1-Tom cells expressing NG2 were most prevalent in the lateral CC in control mice and did not increase after chronic demyelination (Fig. 12I) . Analysis of only NG2 cells that incorporated EdU identified OP cells that continued to proliferate after demyelination, both with and without Gli1-Tom labeling (Fig. 12J-M) .
This contribution of Gli1 fate-labeled cells to the generation of new oligodendrocytes after chronic demyelination was then examined in Gli1
; R26 IAP mice with a longer recovery period to allow visualization of the membranes elaborated during remyelination (Fig. 13) . Gli1
; R26 IAP mice were given TMX on P6-9 and fed CPZ for 12 weeks to induce chronic demyelination followed by a 6 week period on normal chow for spontaneous remyelination (Fig. 13A) . CPZ mice were compared to age matched control mice (No CPZ) perfused at 182 days of age (26 weeks). Control mice illustrate normal myelination of the CC with MOG immunolabeling of myelin (Fig. 13B ). Gli1-AP cells elaborate large clusters of thin membranes parallel to axons consistent with myelin formation in the CC (Fig. 13C-D) . After 12 weeks of CPZ, CC demyelination is evident from loss of MOG immunoreactivity (Fig. 13E) . Gli1-AP cells in the CC have thickened processes and reduced overall AP labeling within the CC (Fig. 13F-G ). After the 6 week period for recovery, MOG immunolabeling is again detected across the CC (Fig. 13H) . Consistent with remyelination, Gli1-AP cells in the CC exhibit long, thin membranes with myelin-like morphology ( Fig. 13I-J ). Gli1-AP membranes appear to also extend along axons in the cingulum after chronic demyelination ( Fig. 13I-J) . These findings indicate that postnatal Shh responsive cells contribute to CC remyelination after chronic demyelination.
Discussion
Understanding the regulatory signals that generate postnatal OP cells is important for designing strategies to optimize the capacity for myelin maintenance and repair in adults. The current study identified cells with active Shh signaling during postnatal development that generate CC oligodendrocytes during postnatal myelination and during remyelination in adults. Crossing of Gli1
CreERT2 mice and Shh
CreERT2
mice to reporter lines demonstrated transient canonical Shh signaling associated with cells populating the CC. Gli1 fate-labeling was evident in the postnatal CC, particularly in lateral regions adjacent to the V-SVZ, when TMX was given from P6-9. Gli1 fate-labeling of cells in the CC was significantly reduced when TMX was delayed until P14-17. Our findings demonstrate active Shh signaling, i.e. Gli1 fate-labeling, during the postnatal wave of oligodendrogenesis. We go on to show that cells which are Gli1 fate-labeled from P6-9 are present in the CC not only during postnatal myelination but continue to be found in the CC in adulthood. Furthermore, this cohort of postnatal Gli1 fate-labeled cells gives rise to oligodendrocyte lineage cells in adults during remyelination in response to either acute or chronic demyelination. We used induced genetic labeling to demonstrate active Shh signaling in vivo during the specific time period of high oligodendrogenesis for postnatal myelination. Importantly, this heritable labeling approach enabled long term in vivo tracking of the fate of this Shh responsive postnatal cohort and subsequent progeny. Heritable labeling at P6-9 was followed out to as long as 26 weeks to examine Gli1 fatelabeled cells in adult mice during homeostasis and in response to chronic demyelination. The Gli1
CreERT2 mouse conditional driver line employed for induced genetic labeling of cells responding to Shh has been characterized to show that reporter labeling corresponds with Gli1 mRNA transcript expression patterns during embryonic development (Ahn and Joyner, 2004) . In addition, Gli1 CreERT2 mice exhibited reporter labeling consistent with Gli1 expression detected by in situ hybridization for mRNA transcripts in adult mice . Gli1 ; R26 tdTomato mice given TMX on postnatal days 6-9 (P6-9) were raised to adulthood and given two doses of EdU to identify cells that had undergone DNA synthesis indicative of cell division within 24 h prior to perfusion (A). EdU detection shows extensive proliferation in the dorsal V-SVZ (dV-SVZ) (B) including Gli1 fate-labeled (Gli1-Tom) cells in lateral extension of the V-SVZ (B, blue arrow). Immunolabeling with NG2 shows Gli1-Tom progenitor cells in the V-SVZ and corpus callosum (B yellow arrows). Immunohistochemistry (IHC) with GFAP identified Gli1-Tom cells as neural stem cells in the dorsal (dV-SVZ) (C, D yellow arrows) and ventral (vV-SVZ) (C, E yellow arrows) V-SVZ. Images shown are representative from n = 4 female mice perfused at P56, with n = 2 given EdU. Scale bars in B, D-E = 50 μm, in C = 100 μ.
exhibit extensive labeling of cells populating the CC after TMX from P6-9 have shown extremely rare labeled cells in the CC after TMX administered to healthy adult mice (Garcia et al., 2010; Mierzwa et al., 2014) . Shh signaling and transcriptional activation targeting Gli1 varies with age and specific localization within germinal zones (Briscoe and Therond, 2013; Alvarez-Buylla and Ihrie, 2014; Tong et al., 2015) . Gli1 expression is highest in ventral regions of the V-SVZ in adult mice Petrova et al., 2013) . In contrast, during early postnatal development Gli1 is also expressed dorsally in the V-SVZ adjacent to the lateral CC. Gli1 mRNA transcripts are enriched in the dorsal V-SVZ at P0 and P7 but diminished by P14 and almost absent by P21 (Tong et al., 2015) . Our experiments in Gli1
CreERT2 mice confirmed that Gli1 expression, as detected by reporter fate-labeling, was high in the V-SVZ between P6-9. Furthermore, with TMX from P6-9 the lateral CC was populated by cells that were Gli1 fate-labeled, which was dramatically reduced with TMX given from P14-17. Shh signaling regulates postnatal oligodendrocyte production from the dorsal V-SVZ. Genetic activation or inactivation of a critical Shh pathway signaling component, Smoothened, in the dorsal V-SVZ increased or decreased oligodendrocyte production, respectively, in early postnatal mice (Tong et al., 2015) . Our experiments provide initial evidence regarding temporal regulation of Shh signaling during this postnatal wave of oligodendrocyte production. We used Shh R26 tdTomato mice were administered TMX on postnatal days 6-9 (P6-P9) and perfused at P56 to identify oligodendrocyte lineage cells (A). Mice were given two injections of a thymidine analogue (EdU) to identify cells that had undergone cell division within 24 h prior to perfusion. Gli1 fate-labeled (Gli1-Tom) cells in the CC include oligodendrocyte lineage cells based on nuclear Olig2 immunoreactivity (B, yellow arrows). Gli1-Tom cells were aligned in rows characteristic of interfascicular oligodendrocytes (B). Immunohistochemistry (IHC) to detect NG2 identified small, elongated process-bearing Gli1-Tom cells as oligodendrocyte progenitors (yellow arrows in C, D). Proliferation of Gli1-Tom oligodendrocyte progenitor cells was evident from EdU incorporation in nuclei of Gli1-Tom cells immunolabeled for NG2 and appearing as doublets (D purple arrows). Scale bar for C shown in B. Images shown are representative from n = 4 female mice perfused at P56 with n = 2 given EdU. Scale bars B, D = 100 μm. Fig. 9 . Tamoxifen (TMX) from postnatal days 6-9 (P6-9) fate labels Shh responsive cells that give rise to astrocytes in the corpus callosum (CC) and in the cortex.
Immunohistochemistry was used to detect expression of the astrocytic marker GFAP in coronal section from Gli1
; R26 tdtomato mice given TMX at P6-9 and perfused at P56. V-SVZ and CC in postnatal Shh CreERT2 mice we identified neurons as the major Shh synthesizing cell type, based on morphology and immunolabeling with NeuN. Comparison of TMX on P6-9 versus P14-17 showed fewer neurons with active Shh ligand transcription after the second postnatal week. The labeling in Shh CreERT2 mice with TMX on P14-17 is consistent with the labeling in cortical neurons with TMX administered in adult Shh CreERT2 mice and in overall distribution in Shh expressing neuronal populations in adult brain using multiple techniques (Garcia et al., 2010; Alvarez-Buylla and Ihrie, 2014) . Therefore, transcriptional control of Shh ligand synthesis corresponds temporally with the transient wave of Shh responsive cells that generate oligodendrocytes in the lateral CC during postnatal myelination. However, Shh transcribing neurons are not closely co-localized with Gli1 fate-labeled cells. Neurons have extensive processes and Shh peptides can have direct short or long-range actions, which may involve secretion through multiple forms of extracellular vesicles (Gritli-Linde et al., 2001; Gradilla et al., 2014; Vyas et al., 2014) . Shh peptides have been shown to bind to astrocytes which then present Shh to OP cells to influence proliferation and migration in developing optic nerve (Merchan et al., 2007; Ortega et al., 2012) . Given this complexity, the spatial distribution of Shh ligand synthesized from Shh transcribing neurons cannot be fully appreciated from the current results. The dorsal V-SVZ developmental site of origin markedly influences the OP population response to demyelination and contribution to remyelination in the adult mouse spinal cord and CC (Crawford et al., 2016) . Specifically, OP cells that are derived from the dorsal V-SVZ populate the forebrain and CC during development, become the majority OP population in the adult CC, and then dominate oligodendrocyte production for remyelination. These studies exploited Emx1-Cre mice crossed to dual fluorescent reporter lines to fate-label cells derived from the dorsal V-SVZ. Our experiments in Gli1
CreERT2 mice extend these findings to show that Shh signaling regulates the postnatal generation of this dorsally derived OP population. Analysis of two time points, P6-9 and P14-17, with an inducible Cre construct delineated the postnatal OP generation period as mainly prior to the second postnatal week. With TMX from P6-9, Gli1 fate-labeled cells in the CC were identified as generating oligodendrocyte lineage cells based on immunolabeling with NG2, Olig2, and CC1 along with formation of myelin-like membranes. Few Gli1 fate-labeled cells populated the postnatal CC when TMX was administered from P14-17. Additional preliminary studies confirmed only rare Gli1 fate-labeling of CC cells with TMX from P14-17 after chronic demyelination (Fig. S4) . Analysis of Shh CreERT2 mice with TMX also from P6-9 and P14-17 illustrated a parallel temporal pattern of labeling to that observed in the Gli1 CreERT2 mice. These concordant results for the Shh ligand synthesis and Shh responsive cells support a model in which Shh signaling regulates the postnatal generation of this dorsally derived OP population that contributes to remyelination after acute or chronic demyelination. CreERT2 ;R26 IAP mice given tamoxifen (TMX) at postnatal days 6-9 (P6-9) were fed 0.3% CPZ starting at P56 (8 weeks of age) and continuing for 6 weeks to induce acute demyelination in the corpus callosum (CC). Mice were perfused at the end of CPZ, or after a recovery period of three weeks with normal chow to allow for remyelination (A). In adult (P56), immunostaining for myelin oligodendrocyte glycoprotein (MOG) shows that the CC is fully myelinated in control mice (No CPZ) (B). Prior to demyelination, the alkaline phosphatase (AP) reporter shows that Gli1 fate-labeled (Gli1-AP) cells extend clusters of membranes along axons consistent with myelin formation in the CC (C, D arrows). After 6 weeks of CPZ feeding, MOG immunolabeling shows extensive demyelination in the CC (E) and many Gli1-AP cells in the CC have long, thickened processes (F, G, arrowheads). In mice given a three week recovery period after ending CPZ, MOG immunolabeling shows extensive remyelination (H) and Gli1-AP cells again have elaborated thin myelin-like membranes in the CC (I, J, arrows). Images shown are representative examples from female mice perfused at P56 No CPZ controls (n = 6) and male mice with 6 weeks CPZ (n = 3), and 6 weeks CPZ + 3 weeks recovery (n = 3). Scale bars in B = 250 μm for B, E, H; in C = 150 μm for C, F, I; in D = 500 μm for D, G, J.
The current studies are the first to demonstrate a connection from Shh responsive cells during postnatal myelination to the CC populations that respond to demyelination in the adult CC. This dorsal population of Shh responsive cells does not appear to overlap completely with the dorsal Emx1 domain of the V-SVZ. Emx1 derived cells distribute throughout the medial and lateral regions of the CC during postnatal development (Kessaris et al., 2006; Tripathi et al., 2011) . In contrast, our results show that the postnatal Shh responsive cells populated more lateral regions of the CC during myelination and in adulthood. This lateral distribution of Gli1 fate-labeled cells was found into adulthood in both male and female mice, and continued during remyelination. More detailed studies would be needed to fully explore the relationship of this transient dorsal Shh population relative to the population derived from the Emx1 domain. ; R26 tdTomato mice administered tamoxifen (TMX) on postnatal days 6-9 (P6-9) and fed 0.3% cuprizone (CPZ) for 12 weeks to induce chronic demyelination of the corpus callosum. At the end of the 12 week period, mice received twice daily injections of EdU, a thymidine analogue, for five days to label cells that undergo cell division during the recovery period on normal chow. Mice were perfused on day 6, which was timed to be 12 h after the last EdU injection. The density of Gli1 fate-labeled (Gli1-Tom) cells was higher in the lateral (L_CC) than medial (M_CC) regions of the CC (B). Gli1-Tom cells in the lateral CC were significantly reduced by chronic demyelination (CPZ) as compared to age matched control mice (No CPZ) (B). Representative images from the lateral CC show the overall distribution of Gli1-Tom cells in the CC in control mice (C) and reduced levels after chronic demyelination (D). Gli1-Tom cells in the CC included astrocytes identified by GFAP (C, D; yellow arrows) that have fine processes in control mice (C) or long, thickened processes of reactive astrocytes after chronic demyelination (D). In control mice (E-H), Gli1-Tom cells were often immunolabeled with CC1, a marker of mature oligodendrocytes (E-G; yellow arrows) and EdU labeled proliferative cells were rare (E, H; arrowheads). After chronic demyelination (I-P), although overall Gli1-Tom cell density is reduced, examples of Gli1-Tom cells labeled by CC1 with EdU incorporation identify new oligodendrocytes generated from Gli1-Tom cells during the recovery period on normal chow (I-P; white arrows). Gli1-Tom cells with the morphology of reactive astrocytes also incorporated EdU after demyelination (M-P, purple arrows). Male mice used in quantification: No CPZ control mice (n = 4), CPZ mice (n = 5). Scale bars in C-D = 100 μm in E, I and M = 50 μm.
Further studies will be of interest to test the implications of this Gli1 fate-labeled postnatal cohort for developmental myelination, adult myelin maintenance, and remyelination. Experimentally induced apoptosis of oligodendrocytes during early postnatal myelination impairs remyelination in adult mice (Caprariello et al., 2015) . Therefore, disruption of normal Shh signaling in oligodendrocyte lineage cells during this postnatal period may have long term implications, and potential vulnerabilies, related to the available pool of OP cells and oligodendrocytes in the adult CC. Through adulthood, new oligodendrocytes are generated for myelin maintenance and activity dependent myelin plasticity (Gibson et al., 2014; McKenzie et al., 2014) . In the case of injury or disease, OP cells are required to generate new oligodendrocytes for myelin repair (Murtie et al., 2005; Powers et al., 2013; Kazanis et al., 2017) . Since we now show that progeny from this postnatal cohort of Shh responsive cells from the dorsal V-SVZ contribute to remyelination in the adult, future studies may also be able to determine whether these cells exhibit different molecular controls that can be targeted to enhance remyelination.
The current results based on postnatal Shh signaling raise questions of whether similar Shh signaling is active during demyelination and remyelination. Prior studies have indicated conflicting roles of Shh signaling, either reporting Shh positively regulates oligodendrocytes for remyelination, or, that Gli1 negatively regulates recruitment of remyelinating cells from the V-SVZ (Ferent et al., 2013; Samanta et al., 2015) . Therefore, our ongoing work is analyzing Shh CreERT2 mice and
Gli1
CreERT2 mice given TMX at multiple time points during the CPZ time course to examine Shh signaling in reactive microglia and astrocytes and in oligodendrocyte lineage cells during acute demyelination or after chronic demyelination. Although beyond the scope of the current study, these ongoing complementary studies using the same reporter lines will determine whether the Shh signaling that is active during postnatal population of the CC may be reactivated during repopulation of the CC after acute or chronic demyelination.
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